| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2022 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 446 | $35.76 | $15,948.96 | -0.3% | +24.9% | +32.2% | |
| Jun 22, 2022 | OPK Opko Health, Inc. | Nabel Gary J. | Chief Innovation Officer | Buy | 240,000 | $2.49 | $597,392.90 | +0.2% | -22.1% | -35.3% | |
| Jun 21, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 200,000 | $2.39 | $478,856.70 | - | -17.6% | -31.8% | |
| Jun 17, 2022 | XWEL Xwell, Inc. | Ernst Ezra | See Remarks | Buy | 12,602 | $0.79 | $10,000.00 | +126.0% | +16.3% | -69.3% | |
| Jun 17, 2022 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 3,440 | $3.29 | $11,317.60 | -1.5% | +19.0% | -36.1% | |
| Jun 17, 2022 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 1,565 | $3.29 | $5,148.85 | -1.1% | +19.0% | -36.1% | |
| Jun 16, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $2.31 | $231,327.47 | - | -10.3% | -33.5% | |
| Jun 15, 2022 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 10,067 | $30.47 | $306,723.37 | -40.6% | +32.5% | -37.8% | |
| Jun 15, 2022 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 6,818 | $3.24 | $22,090.32 | -2.8% | 0.0% | -36.8% | |
| Jun 15, 2022 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 6,818 | $3.24 | $22,090.32 | -4.4% | 0.0% | -36.8% | |
| Jun 15, 2022 | PSNL Personalis, Inc. | Moore Stephen Michael52 | General Counsel | Sell | 1,832 | $3.24 | $5,935.68 | -2.4% | 0.0% | -36.8% | |
| Jun 14, 2022 | VCYT Veracyte, Inc. | Holstein Jens | Director | Sell | 8,720 | $16.27 | $141,846.50 | -81.3% | +28.9% | +63.0% | |
| Jun 13, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $2.36 | $236,498.25 | - | -4.7% | -34.2% | |
| Jun 10, 2022 | VCYT Veracyte, Inc. | Stapley Marc60 | Chief Executive Officer | Buy | 60,000 | $16.33 | $980,094.00 | +60.1% | +18.7% | +58.2% | |
| Jun 8, 2022 | VCYT Veracyte, Inc. | Gordon Kevin K51 | Director | Sell | 15,000 | $18.50 | $277,501.50 | -63.2% | +0.5% | +39.2% | |
| Jun 6, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $2.79 | $279,226.69 | - | -23.2% | -44.9% | |
| Jun 6, 2022 | MYGN Myriad Genetics Inc | Spiegelman Daniel K59 | Director | Sell | 6,424 | $19.25 | $123,672.92 | -15.9% | +14.0% | +20.5% | |
| Jun 2, 2022 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 421 | $3.59 | $1,511.39 | -0.3% | -13.6% | -46.2% | |
| Jun 2, 2022 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 415 | $55.10 | $22,867.33 | -0.3% | -21.4% | -27.1% | |
| Jun 2, 2022 | A Agilent Technologies, Inc. | Thaysen Jacob67 | Sr. Vice President | Sell | 5,879 | $127.43 | $749,178.61 | -6.2% | -0.5% | -8.1% | |
| Jun 2, 2022 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 4,187 | $3.59 | $15,031.33 | -1.7% | -13.6% | -46.2% | |
| Jun 1, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $2.95 | $147,614.00 | - | -25.8% | -53.2% | |
| Jun 1, 2022 | RDNT Radnet, Inc. | Hames Norman R56 | Pres And Coo-west Operations | Sell | 10,000 | $20.53 | $205,310.00 | -3.4% | -0.0% | +45.1% | |
| Jun 1, 2022 | RDNT Radnet, Inc. | Gordon Christine Nayoma | Director | Sell | 2,900 | $20.57 | $59,639.90 | -9.7% | -0.0% | +45.1% | |
| May 31, 2022 | FLGT Fulgent Genetics, Inc. | Bolger John C65 | Director | Sell | 1,126 | $55.32 | $62,291.38 | -8.9% | -17.8% | -27.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.